163 related articles for article (PubMed ID: 6285172)
21. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
De Clercq E
Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
[TBL] [Abstract][Full Text] [Related]
22. The role of cellular- and prodrug-associated factors in the bystander effect induced by the Varicella zoster and Herpes simplex viral thymidine kinases in suicide gene therapy.
Grignet-Debrus C; Cool V; Baudson N; Velu T; Calberg-Bacq CM
Cancer Gene Ther; 2000 Nov; 7(11):1456-68. PubMed ID: 11129288
[TBL] [Abstract][Full Text] [Related]
23. 5-alkynyl analogs of arabinouridine and 2'-deoxyuridine: cytostatic activity against herpes simplex virus and varicella-zoster thymidine kinase gene-transfected cells.
Cristofoli WA; Wiebe LI; De Clercq E; Andrei G; Snoeck R; Balzarini J; Knaus EE
J Med Chem; 2007 Jun; 50(12):2851-7. PubMed ID: 17518459
[TBL] [Abstract][Full Text] [Related]
24. Superior cytotoxicity with ganciclovir compared with acyclovir and 1-beta-D-arabinofuranosylthymine in herpes simplex virus-thymidine kinase-expressing cells: a novel paradigm for cell killing.
Rubsam LZ; Davidson BL; Shewach DS
Cancer Res; 1998 Sep; 58(17):3873-82. PubMed ID: 9731497
[TBL] [Abstract][Full Text] [Related]
25. Enzymatic treatment of formalin-fixed and paraffin-embedded specimens for detection of antigens of herpes simplex, varicella-zoster and human cytomegaloviruses.
Hondo R; Kurata T; Sato S; Oda A; Aoyama Y
Jpn J Exp Med; 1982 Feb; 52(1):17-25. PubMed ID: 6290714
[TBL] [Abstract][Full Text] [Related]
26. Differential metabolism of (E)-5-(2-bromovinyl)-2'-deoxyuridine in wild-type and drug-resistant herpes simplex virus-infected cells.
Ayisi N; Wall R; De Clercq E; Sacks S
Antiviral Res; 1985; Suppl 1():45-9. PubMed ID: 3002265
[No Abstract] [Full Text] [Related]
27. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
Balzarini J; Bohman C; Walker RT; de Clercq E
Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
[TBL] [Abstract][Full Text] [Related]
28. Effects of IMP dehydrogenase inhibitors on the phosphorylation of ganciclovir in MOLT-4 cells before and after herpes simplex virus thymidine kinase gene transduction.
Agbaria R; Mullen CA; Hartman NR; Cooney DA; Hao Z; Blaese RM; Johns DG
Mol Pharmacol; 1994 Apr; 45(4):777-82. PubMed ID: 7910373
[TBL] [Abstract][Full Text] [Related]
29. [Mechanisms of antiherpes drugs and drug resistant virus--effect of BVDU on varicella zoster virus replication].
Shigeta S; Yokota T
Rinsho Byori; 1985 Feb; 33(2):148-57. PubMed ID: 2987573
[No Abstract] [Full Text] [Related]
30. Distinct thymidine kinases encoded by cowpox virus and herpes simplex virus contribute significantly to the differential antiviral activity of nucleoside analogs.
Prichard MN; Williams AD; Keith KA; Harden EA; Kern ER
Antiviral Res; 2006 Aug; 71(1):1-6. PubMed ID: 16530858
[TBL] [Abstract][Full Text] [Related]
31. Adenosine- and ADP-phosphorylating capacity of herpes simplex virus-induced thymidine kinase enzyme complex.
Labenz J; Friedrich D; Müller WE; Falke D
Intervirology; 1983; 19(2):77-84. PubMed ID: 6305867
[TBL] [Abstract][Full Text] [Related]
32. Mutations distal to the substrate site can affect varicella zoster virus thymidine kinase activity: implications for drug design.
El Omari K; Liekens S; Bird LE; Balzarini J; Stammers DK
Mol Pharmacol; 2006 Jun; 69(6):1891-6. PubMed ID: 16556772
[TBL] [Abstract][Full Text] [Related]
33. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
[TBL] [Abstract][Full Text] [Related]
34. Analysis of nucleotide sequence variations in herpes simplex virus types 1 and 2, and varicella-zoster virus.
Chiba A; Suzutani T; Saijo M; Koyano S; Azuma M
Acta Virol; 1998 Dec; 42(6):401-7. PubMed ID: 10358747
[TBL] [Abstract][Full Text] [Related]
35. Metabolic fate of (E)-5-(2-bromovinyl)-2'-deoxyuridine in herpes simplex virus- and mock-infected cells.
Ayisi NK; De Clercq E; Wall RA; Hughes H; Sacks SL
Antimicrob Agents Chemother; 1984 Nov; 26(5):762-5. PubMed ID: 6097176
[TBL] [Abstract][Full Text] [Related]
36. Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases.
Cheng YC; Dutschman G; Fox JJ; Watanabe KA; Machida H
Antimicrob Agents Chemother; 1981 Sep; 20(3):420-3. PubMed ID: 6272634
[TBL] [Abstract][Full Text] [Related]
37. Enzyme prodrug gene therapy: synergistic use of the herpes simplex virus-cellular thymidine kinase/ganciclovir system and thymidylate synthase inhibitors for the treatment of colon cancer.
Wildner O; Blaese RM; Candotti F
Cancer Res; 1999 Oct; 59(20):5233-8. PubMed ID: 10537302
[TBL] [Abstract][Full Text] [Related]
38. Deoxythymidine kinase induced in the HELA TK- cells by herpes simplex virus type I and type II. Substrate specificity and kinetic behavior.
Cheng YC
Biochim Biophys Acta; 1976 Dec; 452(2):370-81. PubMed ID: 188465
[TBL] [Abstract][Full Text] [Related]
39. Metabolism and mode of inhibition of varicella-zoster virus by L-beta-5-bromovinyl-(2-hydroxymethyl)-(1,3-dioxolanyl)uracil is dependent on viral thymidine kinase.
Li L; Dutschman GE; Gullen EA; Tsujii E; Grill SP; Choi Y; Chu CK; Cheng YC
Mol Pharmacol; 2000 Nov; 58(5):1109-14. PubMed ID: 11040060
[TBL] [Abstract][Full Text] [Related]
40. Varicella-zoster virus (VZV) ORF65 virion protein is dispensable for replication in cell culture and is phosphorylated by casein kinase II, but not by the VZV protein kinases.
Cohen JI; Sato H; Srinivas S; Lekstrom K
Virology; 2001 Feb; 280(1):62-71. PubMed ID: 11162819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]